Wednesday, January 12, 2011

4Life Announces New Exclusive Patent

From the very beginning, Bianca and I knew that we wanted 4Life to be a company that would break new ground in both products and financial opportunity. We didn't want 4Life to be "just another company." We'd had experience with other good companies before, but we knew that it would not be worth our time to create something that might be good, but not great. We realized that the strength of 4Life would need to be founded in cutting-edge research—hence the name, 4Life Research. The word "research" was not just tagged onto 4Life because we thought it sounded good. Research defines who we are and our commitment to scientifically-based products that cannot be found anywhere else.

Patent protection is just one way that we work to achieve this end—to empower 4Life distributors with exclusivity and credibility in the marketplace. Recently, 4Life announced that the United States Patent & Trademark Office (USPTO) awarded the company a composition patent that protects the 4Life Transfer Factor® Cardio formula until 2025. This is our sixth worldwide patent. We also have numerous international patents and dozens of patent applications pending.

Congratulations to all who have been working on this tremendous achievement. Together, building products... together, building patents... and together, building businesses. These are all great ways to achieve our goal of Together, Building People.

For additional information, including an executive video announcement, visit the 4Life Digital NewsStand at